{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/EVMN/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-08T14:15:37.732Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":7698,"canonical_name":"Evommune, Inc.","cik":"0002044725","uei":null,"lei":null,"duns":null,"ticker":"EVMN"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":35},"count":35,"timeline":[{"ts":"2026-07-08","kind":"sec.insider.1000.00","reporter":"Carver Kyle","title":"Chief Financial Officer","shares":1000,"price_per_share":13.26,"usd_value":13260,"security_title":"Common Stock","importance":15.01326},{"ts":"2026-07-07","kind":"sec.insider.p","reporter":"KIRSCH ARTHUR S","title":"","shares":10000,"price_per_share":13.3,"usd_value":133000,"security_title":"Common Stock","importance":50.133},{"ts":"2026-07-07","kind":"sec.insider.10000.00","reporter":"KIRSCH ARTHUR S","title":null,"shares":10000,"price_per_share":13.3,"usd_value":133000,"security_title":"Common Stock","importance":15.133},{"ts":"2026-06-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Evommune, Inc. — 2026-06-29","url_slug":"/sec/cik-0002044725/8-k/0001193125-26-286918","accession_number":"0001193125-26-286918","importance":35},{"ts":"2026-06-29","kind":"sec.filing","form_type":"424B3","title":"424B3 — Evommune, Inc. — 2026-06-29","url_slug":"/sec/cik-0002044725/424b3/0001193125-26-286924","accession_number":"0001193125-26-286924","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — Evommune, Inc. — 2026-06-24","url_slug":"/sec/cik-0002044725/4/0002091053-26-000005","accession_number":"0002091053-26-000005","importance":30},{"ts":"2026-06-24","kind":"sec.filing","form_type":"4","title":"4 — Evommune, Inc. — 2026-06-24","url_slug":"/sec/cik-0002044725/4/0002092017-26-000007","accession_number":"0002092017-26-000007","importance":30},{"ts":"2026-06-22","kind":"sec.form144","reporter":"JANICE DREW","title":"Officer","shares":20000,"usd_value":427200,"security_title":"Common","approx_sale_date":"2026-06-22","accession_number":"0001950047-26-006381","importance":40.08544},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Drew Janice Suzann","title":"Chief of Dev. Operations","shares":20000,"price_per_share":22.63,"usd_value":452600,"security_title":"Common Stock","importance":35.4526},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Pena Luis C.","title":"President & CEO","shares":7438,"price_per_share":22.71,"usd_value":168917,"security_title":"Common Stock","importance":35.16891698},{"ts":"2026-06-22","kind":"sec.insider.s","reporter":"Patel Jeegar Pravinkumar","title":"Chief Scientific Officer","shares":1488,"price_per_share":22.5,"usd_value":33480,"security_title":"Common Stock","importance":35.03348},{"ts":"2026-06-22","kind":"sec.filing","form_type":"144","title":"144 — Evommune, Inc. — 2026-06-22","url_slug":"/sec/cik-0002044725/144/0001950047-26-006381","accession_number":"0001950047-26-006381","importance":30},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Drew Janice Suzann","title":"Chief of Dev. Operations","shares":16161,"price_per_share":2.99,"usd_value":48321,"security_title":"Common Stock","importance":15.04832139},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Drew Janice Suzann","title":"Chief of Dev. Operations","shares":3839,"price_per_share":3.84,"usd_value":14742,"security_title":"Common Stock","importance":15.01474176},{"ts":"2026-06-22","kind":"sec.insider.m","reporter":"Patel Jeegar Pravinkumar","title":"Chief Scientific Officer","shares":1488,"price_per_share":3.84,"usd_value":5714,"security_title":"Common Stock","importance":15.00571392},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — Evommune, Inc. — 2026-06-03","url_slug":"/sec/cik-0002044725/4/0002092017-26-000005","accession_number":"0002092017-26-000005","importance":30},{"ts":"2026-06-02","kind":"sec.form144","reporter":"DAVID COHEN","title":"Director","shares":9258,"usd_value":205250,"security_title":"Common","approx_sale_date":"2026-06-02","accession_number":"0001950047-26-005513","importance":40.041049972},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Cohen David E","title":"","shares":5456,"price_per_share":20.21,"usd_value":110266,"security_title":"Common Stock","importance":35.11026576},{"ts":"2026-06-02","kind":"sec.insider.s","reporter":"Cohen David E","title":"","shares":600,"price_per_share":21.38,"usd_value":12828,"security_title":"Common Stock","importance":35.012828},{"ts":"2026-06-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Evommune, Inc. — 2026-06-02","url_slug":"/sec/cik-0002044725/8-k/0001193125-26-253482","accession_number":"0001193125-26-253482","importance":35},{"ts":"2026-06-02","kind":"sec.filing","form_type":"424B3","title":"424B3 — Evommune, Inc. — 2026-06-02","url_slug":"/sec/cik-0002044725/424b3/0001193125-26-253489","accession_number":"0001193125-26-253489","importance":30},{"ts":"2026-06-01","kind":"sec.form144","reporter":"LUIS PENA","title":"Director, Officer","shares":24225,"usd_value":562747,"security_title":"Common","approx_sale_date":"2026-06-01","accession_number":"0001950047-26-005432","importance":40.11254935},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Pena Luis C.","title":"President & CEO","shares":16787,"price_per_share":22.74,"usd_value":381736,"security_title":"Common Stock","importance":35.38173638},{"ts":"2026-06-01","kind":"sec.insider.s","reporter":"Patel Jeegar Pravinkumar","title":"Chief Scientific Officer","shares":16687,"price_per_share":22.74,"usd_value":379462,"security_title":"Common Stock","importance":35.37946238},{"ts":"2026-06-01","kind":"sec.filing","form_type":"144","title":"144 — Evommune, Inc. — 2026-06-01","url_slug":"/sec/cik-0002044725/144/0001950047-26-005430","accession_number":"0001950047-26-005430","importance":30},{"ts":"2026-06-01","kind":"sec.insider.m","reporter":"Patel Jeegar Pravinkumar","title":"Chief Scientific Officer","shares":13512,"price_per_share":3.84,"usd_value":51886,"security_title":"Common Stock","importance":15.05188608},{"ts":"2026-05-28","kind":"sec.insider.s","reporter":"Carver Kyle","title":"Chief Financial Officer","shares":18175,"price_per_share":22.84,"usd_value":415117,"security_title":"Common Stock","importance":35.415117},{"ts":"2026-05-28","kind":"sec.insider.s","reporter":"Moss Gregory S.","title":"Chief Business & Legal Officer","shares":14223,"price_per_share":22.83,"usd_value":324711,"security_title":"Common Stock","importance":35.32471109},{"ts":"2026-05-28","kind":"sec.insider.18175.00","reporter":"Carver Kyle","title":"Chief Financial Officer","shares":18175,"price_per_share":22.84,"usd_value":415117,"security_title":"Common Stock","importance":15.415117},{"ts":"2026-05-28","kind":"sec.insider.14223.00","reporter":"Moss Gregory S.","title":"Chief Business & Legal Officer","shares":14223,"price_per_share":22.83,"usd_value":324711,"security_title":"Common Stock","importance":15.32471109},{"ts":"2026-05-28","kind":"sec.insider.15000.00","reporter":"Carver Kyle","title":"Chief Financial Officer","shares":15000,"price_per_share":2.99,"usd_value":44850,"security_title":"Common Stock","importance":15.04485},{"ts":"2026-05-28","kind":"sec.insider.m","reporter":"Carver Kyle","title":"Chief Financial Officer","shares":15000,"price_per_share":2.99,"usd_value":44850,"security_title":"Common Stock","importance":15.04485},{"ts":"2026-05-28","kind":"sec.insider.14223.00","reporter":"Moss Gregory S.","title":"Chief Business & Legal Officer","shares":14223,"price_per_share":1.71,"usd_value":24321,"security_title":"Common Stock","importance":15.02432133},{"ts":"2026-05-28","kind":"sec.insider.m","reporter":"Moss Gregory S.","title":"Chief Business & Legal Officer","shares":14223,"price_per_share":1.71,"usd_value":24321,"security_title":"Common Stock","importance":15.02432133},{"ts":"2026-04-24","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Evommune, Inc. — 2026-04-24","url_slug":"/sec/cik-0002044725/effect/9999999995-26-001330","accession_number":"9999999995-26-001330","importance":30}]}